Your browser doesn't support javascript.
loading
A primer on rectal MRI in patients on watch-and-wait treatment for rectal cancer.
Gollub, Marc J; Costello, James R; Ernst, Randy D; Lee, Sonia; Maheshwari, Ekta; Petkovska, Iva; Wasnik, Ashish P; Horvat, Natally.
Afiliação
  • Gollub MJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. gollubm@mskcc.org.
  • Costello JR; Department of Diagnostic Imaging and Intervention, Motiff Cancer Center, Tampa, FL, 33612, USA.
  • Ernst RD; Division of Diagnostic Imaging, Department of Abdominal Imaging, MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Lee S; Department of Radiology, University of California, Irvine, Orange, CA, 92868, USA.
  • Maheshwari E; Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.
  • Petkovska I; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Wasnik AP; Department of Radiology, University of MI-Michigan Medicine, Ann Arbor, MI, 48109, USA.
  • Horvat N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Abdom Radiol (NY) ; 48(9): 2836-2873, 2023 09.
Article em En | MEDLINE | ID: mdl-37099182
ABSTRACT
Total neoadjuvant treatment (TNT) for rectal cancer is becoming an accepted treatment paradigm and is changing the landscape of this disease, wherein up to 50% of patients who undergo TNT are able to avoid surgery. This places new demands on the radiologist in terms of interpreting degrees of response to treatment. This primer summarizes the Watch-and-Wait approach and the role of imaging, with illustrative "atlas-like" examples as an educational guide for radiologists. We present a brief literature summary of the evolution of rectal cancer treatment, with a focus on magnetic resonance imaging (MRI) assessment of response. We also discuss recommended guidelines and standards. We outline the common TNT approach entering mainstream practice. A heuristic and algorithmic approach to MRI interpretation is also offered. To illustrate management and common scenarios, we arranged the illustrative figures as follows (I) Clinical complete response (cCR) achieved at the immediate post-TNT "decision point" scan time; (II) cCR achieved at some point during surveillance, later than the first post-TNT MRI; (III) near clinical complete response (nCR); (IV) incomplete clinical response (iCR); (V) discordant findings between MRI and endoscopy where MRI is falsely positive, even at follow-up; (VI) discordant cases where MRI seems to be falsely positive but is proven truly positive on follow-up endoscopy; (VII) cases where MRI is falsely negative; (VIII) regrowth of tumor in the primary tumor bed; (IX) regrowth outside the primary tumor bed; and (X) challenging scenarios, i.e., mucinous cases. This primer is offered to achieve its intended goal of educating radiologists on how to interpret MRI in patients with rectal cancer undergoing treatment using a TNT-type treatment paradigm and a Watch-and-Wait approach.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais Idioma: En Ano de publicação: 2023 Tipo de documento: Article